Blockchain Adoption for Generic Drugs in the Medicine Supply Chain with Consumers’ Risk-Aversion: A Game-Theoretic Model Within Chinese Legal Framework

References

• Dunne SS, Dunne CP. What do people really think of generic medicines? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugs. BMC Med. 2015;13(1):1–27. doi:10.1186/s12916-015-0415-3
   PubMedGoogle Scholar
• What is the difference between brand-name and generic drugs? 2021. Available from: https://www.medicalnewstoday.com/articles/brand-and-generic-drugs. Accessed 28, June, 2021.
   Google Scholar
• Generic Drugs Market; 2022. Available from: https://www.precedenceresearch.com/generic-drugs-market. Accessed August, 2022.
   Google Scholar
• The top 10 generic drug makers by 2021 revenue; 2022. Available from: https://www.fiercepharma.com/pharma/top-10-generic-drugmakers-2021-revenue. Accessed 18, July, 2022.
   Google Scholar
• Our 12 Picks for Online Pharmacies of 2023; 2023. Available from: https://www.verywellhealth.com/best-online-pharmacies-4842630. Accessed 21, April, 2023.
   Google Scholar
• Carrera M, Villas-Boas S. Generic aversion and observational learning in the over-The-counter drug market. Am Econ J Appl Econ. 2023;15(3):380–410.
   Web of Science ®Google Scholar
• Idris IM, Hassan DN, Hassen HA, Araya RZ, Weldemariam DG. Consumers’ perception of generic medicines and evaluation of in vitro quality control parameters of locally manufactured paracetamol tablets in Asmara, Eritrea: a cross-sectional study. Biomed Res. Int. 2021;2021:1–7. doi:10.1155/2021/4014797
   PubMed Web of Science ®Google Scholar
• Greco C. Generic manufacturers can make big changes with blockchain technology. Blockchain Healthcare Today. 2023;6(1). doi:10.30953/bhty.v6.254
   Google Scholar
• Disrupting Pharma Industry with Blockchain; 2023. Available from: https://www.nitorinfotech.com/blog/disrupting-pharma-industry-with-blockchain/. Accessed 01, September, 2023.
   Google Scholar
• A blockchain solution to eroding trust in the pharmaceutical model; 2022. Available from: https://www.bsvblockchain.org/news/a-blockchain-solution-to-eroding-trust-in-The-pharmaceutical-model. Accessed 19, April, 2022.
   Google Scholar
• Shen B, Xu X, Yuan Q. Selling secondhand products through an online platform with blockchain. Trans Res Part E Logistics Transport Rev. 2020;142:102066. doi:10.1016/j.tre.2020.102066
   PubMed Web of Science ®Google Scholar
• Pun H, Swaminathan JM, Hou P. Blockchain adoption for combating deceptive counterfeits. Prod Oper Manage. 2021;30(4):864–882. doi:10.1111/poms.13348
   Web of Science ®Google Scholar
• Zhang Z, Ren D, Lan Y, Yang S. Price competition and blockchain adoption in retailing markets. Eur J Oper Res. 2022;300(2):647–660. doi:10.1016/j.ejor.2021.08.027
   Web of Science ®Google Scholar
• Li Z, Xu X, Bai Q, Guan X, Zeng K. The interplay between blockchain adoption and channel selection in combating counterfeits. Trans Res Part E Logistics Transport Rev. 2021;155:102451. doi:10.1016/j.tre.2021.102451
   Web of Science ®Google Scholar
• Yang L, Gao M, Feng L. Competition versus cooperation? Which is better in a remanufacturing supply chain considering blockchain. Trans Res Part E Logistics Transport Rev. 2022;165:102855. doi:10.1016/j.tre.2022.102855
   Web of Science ®Google Scholar
• Xu X, Yan L, Choi TM, Cheng T. When is it wise to use blockchain for platform operations with remanufacturing? Eur J Oper Res. 2023;309(3):1073–1090. doi:10.1016/j.ejor.2023.01.063
   Web of Science ®Google Scholar
• Wang Z, Zheng Z, Jiang W, Tang S. Blockchain-enabled data sharing in supply chains: model, operationalization, and tutorial. Prod Oper Manage. 2021;30(7):1965–1985. doi:10.1111/poms.13356
   Web of Science ®Google Scholar
• Freeman JA, Hill A. The use of generic medications for hepatitis c. Liver Int. 2016;36(7):929–932. doi:10.1111/liv.13157
   PubMed Web of Science ®Google Scholar
• Gupta K, Dixit A, Routroy S, Dubey SK. Government supported generic drug supply chain in India: a study on critical success factors. Evid Based Manage. 2017;253.
   Google Scholar
• Dave CV, Kesselheim AS, Fox ER, Qiu P, Hartzema A. High generic drug prices and market competition: a retrospective cohort study. Ann Internal Med. 2017;167(3):145–151. doi:10.7326/M16-1432
   PubMed Web of Science ®Google Scholar
• Aivalli PK, Elias MA, Pati MK, et al. Perceptions of the quality of generic medicines: implications for trust in public services within the local health system in Tumkur, India. BMJ Global Health. 2018;2(Suppl 3):e000644. doi:10.1136/bmjgh-2017-000644
   PubMedGoogle Scholar
• Guerin PJ, Singh-Phulgenda S, Strub-Wourgaft N. The consequence of covid-19 on the global supply of medical products: why Indian generics matter for the world? F1000Research. 2020;9:225. doi:10.12688/f1000research.23057.1
   PubMedGoogle Scholar
• Kumar D. Analysis of issues of generic medicine supply chain using fuzzy AHP: a pilot study of Indian public drug distribution scheme. Int J Pharm Healthcare Marketing. 2021;15(1):18–42. doi:10.1108/IJPHM-12-2019-0078
   Web of Science ®Google Scholar
• Ahlqvist V, Dube N, Jahre M, et al. Supply chain risk management strategies in normal and abnormal times: policymakers’ role in reducing generic medicine shortages. Int J Phys Distrib Logist Manage. 2023;53(2):206–230. doi:10.1108/IJPDLM-12-2021-0511
   Web of Science ®Google Scholar
• Yoo SH. Product quality and return policy in a supply chain under risk aversion of a supplier. Int J Prod Econ. 2014;154:146–155. doi:10.1016/j.ijpe.2014.04.012
   Web of Science ®Google Scholar
• Ke H, Wu Y, Huang H. Competitive pricing and remanufacturing problem in an uncertain closed-loop supply chain with risk-sensitive retailers. Asia-Pacific J Oper Res. 2018;35(01):1850003. doi:10.1142/S0217595918500033
   Google Scholar
• Alamdar S, Rabbani M, Heydari J. Optimal decision problem in a three-level closed-loop supply chain with risk-averse players under demand uncertainty. Uncertain Supply Chain Management. 2019;7(2):351–368. doi:10.5267/j.uscm.2018.7.002
   Google Scholar
• Abbey JD, Kleber R, Souza GC, Voigt G. Remanufacturing and consumers’ risky choices: behavioral modeling and the role of ambiguity aversion. J Oper Manage. 2019;65(1):4–21. doi:10.1002/joom.1001
   Web of Science ®Google Scholar
• Deng W. Sustainable development: impacts of consumers’ risk aversion on remanufacturing model selection and environmental performance. Sust Develop. 2020;28(6):1564–1574. doi:10.1002/sd.2105
   Web of Science ®Google Scholar
• Adhikari A, Bisi A, Avittathur B. Coordination mechanism, risk sharing, and risk aversion in a five-level textile supply chain under demand and supply uncertainty. Eur J Oper Res. 2020;282(1):93–107. doi:10.1016/j.ejor.2019.08.051
   Web of Science ®Google Scholar
• Gupta V, Ivanov D. Dual sourcing under supply disruption with risk-averse suppliers in the sharing economy. Int J P Res. 2020;58(1):291–307. doi:10.1080/00207543.2019.1686189
   Web of Science ®Google Scholar
• Niu B, Dong J, Liu Y. Incentive alignment for blockchain adoption in medicine supply chains. Trans Res Part E Logistics Transport Rev. 2021;152:102276. doi:10.1016/j.tre.2021.102276
   Web of Science ®Google Scholar
• Idris IM, Hassan DN, Hassen HA, Araya RZ, Weldemariam DG. Consumers’ Perception of Generic Medicines and Evaluation of In Vitro Quality Control Parameters of Locally Manufactured Paracetamol Tablets in Asmara, Eritrea: a Cross-Sectional Study. Biomed Res. Int. 2021;2021:1–7.
   PubMed Web of Science ®Google Scholar
• Hussar DA. Is the quality of generic drugs cause for concern? J Managed Care Specialty Pharmacy. 2020;26(5):597–599. doi:10.18553/jmcp.2020.26.5.597
   PubMed Web of Science ®Google Scholar
• Yang W, Zhang J, Yan H. Impacts of online consumer reviews on a dual-channel supply chain. Omega. 2021;101:102266. doi:10.1016/j.omega.2020.102266
   Web of Science ®Google Scholar
• Kohli E, Buller A. Factors influencing consumer purchasing patterns of generic versus brand name over-The-counter drugs. South Med J. 2013;106(2):155–160. doi:10.1097/SMJ.0b013e3182804c58
   PubMed Web of Science ®Google Scholar
• Wen X, Siqin T. How do product quality uncertainties affect the sharing economy platforms with risk considerations? A mean-variance analysis. Int J Prod Econ. 2020;224:107544. doi:10.1016/j.ijpe.2019.107544
   Web of Science ®Google Scholar
• Ha AY, Tian Q, Tong S. Information sharing in competing supply chains with production cost reduction. Manuf Serv Oper Manage. 2017;19(2):246–262. doi:10.1287/msom.2016.0607
   Google Scholar
• Ericson WA. A note on the posterior mean of a population mean. J Royal Statistical Soc. 1969;31(2):332–334.
   Google Scholar
• Örsdemir EA, Kemahlıoğlu‐Ziya E, Parlaktürk AK. Competitive quality choice and remanufacturing. Prod Oper Manage. 2014;23(1):48–64. doi:10.1111/poms.12040
   Web of Science ®Google Scholar
• Wang T, Thomas DJ, Rudi N. The effect of competition on the efficient–responsive choice. Prod Oper Manage. 2014;23(5):829–846. doi:10.1111/poms.12093
   Web of Science ®Google Scholar
• Qiao H, Su Q. Distribution channel and licensing strategy choice considering consumer online reviews in a closed-loop supply chain. Trans Res Part E Logistics Transport Rev. 2021;151:102338. doi:10.1016/j.tre.2021.102338
   Web of Science ®Google Scholar